Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-CHEK1 Antibody (R1D26)

Catalog #:   RHA29001 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: WB
Accession: O14757
Overview

Catalog No.

RHA29001

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

WB: 1:500-1:1000

Target

Cell cycle checkpoint kinase, Serine/threonine-protein kinase Chk1, Checkpoint kinase-1, CHK1, CHK1 checkpoint homolog, CHEK1

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

O14757

Applications

WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R1D26

Data Image
  • Western blot
    Western blot analysis of Chk1 in K562 lysates using Chk1 antibody.
  • Western blot
    Western blot analysis of Chk1 in K562, 3T3, Hela lysates using Chk1 antibody.
References

Co-inhibition of Notch1 and ChK1 triggers genomic instability and melanoma cell death increasing the lifespan of mice bearing melanoma brain metastasis., PMID:40437523

Uncovering miRNA-mRNA Regulatory Networks Related to Olaparib Resistance and Resensitization of BRCA2MUT Ovarian Cancer PEO1-OR Cells with the ATR/CHK1 Pathway Inhibitors., PMID:38786089

The luciferase-based in vivo protein-protein interaction assay revealed that CHK1 promotes PP2A and PME-1 interaction., PMID:38588804

AMT-562, a Novel HER3-targeting Antibody-Drug Conjugate, Demonstrates a Potential to Broaden Therapeutic Opportunities for HER3-expressing Tumors., PMID:37302522

Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options., PMID:36991316

Inferring tumor-specific cancer dependencies through integrating ex vivo drug response assays and drug-protein profiling., PMID:35994503

CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer., PMID:34474677

Determination of CHK1 Cellular Localization by Immunofluorescence Microscopy., PMID:33786781

In search for biomarkers and potential drug targets for uterine serous endometrial cancer., PMID:33754208

Targeting IGF Perturbs Global Replication through Ribonucleotide Reductase Dysfunction., PMID:33509941

Mutations in DNA Repair Genes and Clinical Outcomes of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin or Irinotecan-containing Regimens., PMID:33298767

Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment., PMID:32778095

Targeting Topoisomerase I in the Era of Precision Medicine., PMID:31227499

RPA-coated single-stranded DNA promotes the ETAA1-dependent activation of ATR., PMID:30975033

CHK1 dosage in germinal center B cells controls humoral immunity., PMID:30894677

A common Chk1-dependent phenotype of DNA double-strand break suppression in two distinct radioresistant cancer types., PMID:30607635

Expression, activation and clinical relevance of CHK1 and CHK2 in metastatic high-grade serous carcinoma., PMID:29804637

Checkpoint kinase 1-induced phosphorylation of O-linked β-N-acetylglucosamine transferase regulates the intermediate filament network during cytokinesis., PMID:29021254

Donor-Derived Metastatic Melanoma and Checkpoint Inhibition., PMID:28838438

Combining Chk1/2 Inhibition with Cetuximab and Radiation Enhances In Vitro and In Vivo Cytotoxicity in Head and Neck Squamous Cell Carcinoma., PMID:28138028

Loss of Glis2/NPHP7 causes kidney epithelial cell senescence and suppresses cyst growth in the Kif3a mouse model of cystic kidney disease., PMID:27181777

DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1., PMID:27026201

Key mediators of somatic ATR signaling localize to unpaired chromosomes in spermatocytes., PMID:26209650

And-1 coordinates with Claspin for efficient Chk1 activation in response to replication stress., PMID:26082189

Checkpoint kinase 2 is required for efficient immunoglobulin diversification., PMID:25483076

ATR/Chk1/Smurf1 pathway determines cell fate after DNA damage by controlling RhoB abundance., PMID:25249323

Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinoma., PMID:24838526

CH-01 is a hypoxia-activated prodrug that sensitizes cells to hypoxia/reoxygenation through inhibition of Chk1 and Aurora A., PMID:23597309

Global analysis of phosphorylation of tau by the checkpoint kinases Chk1 and Chk2 in vitro., PMID:23550703

Rad9, Rad17, TopBP1 and claspin play essential roles in heat-induced activation of ATR kinase and heat tolerance., PMID:23383325

Chk1 and Mps1 jointly regulate correction of merotelic kinetochore attachments., PMID:23321637

Sensitization of tumor to ²¹²Pb radioimmunotherapy by gemcitabine involves initial abrogation of G2 arrest and blocked DNA damage repair by interference with Rad51., PMID:23200172

Screening for novel LRRK2 inhibitors using a high-throughput TR-FRET cellular assay for LRRK2 Ser935 phosphorylation., PMID:22952710

CHK1 kinase activity assay., PMID:22941630

Epstein-Barr virus-encoded latent membrane protein 1 impairs G2 checkpoint in human nasopharyngeal epithelial cells through defective Chk1 activation., PMID:22761726

Human embryonic stem cells fail to activate CHK1 and commit to apoptosis in response to DNA replication stress., PMID:22553144

Disruption of murine mp29/Syf2/Ntc31 gene results in embryonic lethality with aberrant checkpoint response., PMID:22448250

Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy., PMID:22117197

Methods for studying checkpoint kinases - Chk1., PMID:21870291

Parvovirus B19 infection of human primary erythroid progenitor cells triggers ATR-Chk1 signaling, which promotes B19 virus replication., PMID:21680529

Alterations of ATM and CADM1 in chromosomal 11q22.3-23.2 region are associated with the development of invasive cervical carcinoma., PMID:21643982

Nuclear Chk1 prevents premature mitotic entry., PMID:21628425

Sonic hedgehog signaling protects human hepatocellular carcinoma cells against ionizing radiation in an autocrine manner., PMID:21377281

Premature chromosome condensation induced by caffeine, 2-aminopurine, staurosporine and sodium metavanadate in S-phase arrested HeLa cells is associated with a decrease in Chk1 phosphorylation, formation of phospho-H2AX and minor cytoskeletal rearrangements., PMID:21347609

Nek1 kinase functions in DNA damage response and checkpoint control through a pathway independent of ATM and ATR., PMID:21301226

Ataxia telangiectasia and Rad3-related overexpressing cancer cells induce prolonged G₂ arrest and develop resistance to ionizing radiation., PMID:21294646

Synergistic effects of topoisomerase I inhibitor, SN38, on Fas-mediated apoptosis., PMID:21036702

Chk1-dependent constitutive phosphorylation of BLM helicase at serine 646 decreases after DNA damage., PMID:20719863

MCL-1 localizes to sites of DNA damage and regulates DNA damage response., PMID:20647761

Adenovirus 12 E4orf6 inhibits ATR activation by promoting TOPBP1 degradation., PMID:20566845

Datasheet

Document Download

Anti-CHEK1 Antibody (R1D26).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-CHEK1 Antibody (R1D26) [RHA29001]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only